[The Short-Form impairment index (SFII) in schizophrenic patients]

Area of Science:

• Psychiatry
• Neuropsychology
• Cognitive Science

Background:

• Schizophrenia is a complex mental disorder characterized by cognitive impairments.
• Assessing cognitive function is crucial for understanding schizophrenia's impact.
• The Short-Form Impairment Index (SFII) is a tool for evaluating cognitive deficits.

Purpose of the Study:

• To evaluate cognitive impairment in schizophrenia patients using the SFII.
• To investigate the relationship between cognitive impairment and positive/negative symptoms of schizophrenia.
• To determine the SFII's utility as a marker for cognitive functioning in schizophrenia.

Main Methods:

• Two samples of schizophrenia patients (N=30 inpatients, N=19 day hospital) were studied.
• Cognitive impairment was assessed using the SFII, including Trail Making B, WAIS cubes, and digit symbol subtests.
• Positive and negative symptoms were measured using the Andreasen scales (SAPS and SANS).

Main Results:

• No significant differences in epidemiological variables were found between the two patient samples.
• A significant negative correlation was observed between SFII scores (cognitive impairment) and negative symptoms in both samples.
• Higher cognitive impairment (lower SFII scores) was associated with more severe negative symptoms.

Conclusions:

• The SFII is a potentially valuable tool for assessing cognitive functioning in post-acute and mixed schizophrenia populations.
• The SFII's correlation with negative symptoms suggests its relevance in understanding schizophrenia's clinical presentation.
• Age-corrected values of the SFII may have limitations in younger patient samples.